Article ID Journal Published Year Pages File Type
2774156 Endocrinología y Nutrición 2011 10 Pages PDF
Abstract
The BRAFT1799A mutation is associated to age over 60 and a tumor size of 1 cm or greater, but not to other clinicopathological characteristics, tumor recurrence or PTC persistence.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Clinical Biochemistry
Authors
, , , , , , , , ,